We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 34.84%
2 Financials 13.62%
3 Communication Services 11.15%
4 Technology 9.41%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHL
101
DELISTED
Achilles Therapeutics
ACHL
$16.6M 0.08%
+1,000,000
New +$16.6M
ZEAL
102
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$16.3M 0.08%
510,000
– –
RCEL icon
103
Avita Medical
RCEL
$240M
$15.9M 0.08%
+800,000
New +$18.6M
BEKE icon
104
KE Holdings
BEKE
$18.8B
$15.6M 0.08%
273,000
-70,000
-20% -$4.4M
RCKT icon
105
Rocket Pharmaceuticals
RCKT
$394M
$15.5M 0.08%
350,000
+150,000
+75% +$8.24M
ASZ.U
106
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
$15M 0.07%
+1,500,000
New +$15.2M
KAHC.U
107
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
$15M 0.07%
+1,500,000
New +$15M
ADVM
108
DELISTED
Adverum Biotechnologies
ADVM
$14.8M 0.07%
150,000
– –
STAY
109
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$14.1M 0.07%
+715,499
New +$11.7M
DISAU
110
DELISTED
Disruptive Acquisition Corporation I Unit
DISAU
$13.8M 0.07%
+1,400,000
New +$13.8M
DCPH
111
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$13.5M 0.07%
300,000
– –
LBPH
112
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$13.3M 0.07%
+810,500
New +$13.2M
CMRX
113
DELISTED
Chimerix, Inc.
CMRX
$12.5M 0.06%
+1,300,000
New +$11.9M
FRXB.U
114
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
$12.4M 0.06%
+1,250,000
New +$12.6M
GRFS
115
Grifois
GRFS
$5.4B
$12.1M 0.06%
702,110
-412,890
-37% -$7.14M
INBX
116
DELISTED
Inhibrx, Inc. Common Stock
INBX
$12M 0.06%
600,000
+90,000
+18% +$2.63M
AGGRU
117
DELISTED
Agile Growth Corp Units
AGGRU
$11.9M 0.06%
+1,200,000
New +$11.9M
DRIO icon
118
DarioHealth
DRIO
$71.2M
$11.6M 0.06%
+30,000
New +$13.5M
ARWR icon
119
Arrowhead Research
ARWR
$12.4B
$11.4M 0.06%
172,454
+104,854
+155% +$8.14M
CRIS icon
120
Curis
CRIS
$7.83M
$11.3M 0.06%
2,500
+687
+38% +$2.87M
KURA icon
121
Kura Oncology
KURA
$850M
$11.3M 0.06%
400,000
+275,000
+220% +$8.7M
NGM
122
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$10.9M 0.05%
+375,000
New +$10.5M
GRND icon
123
Grindr
GRND
$2.95B
$10.8M 0.05%
+1,080,000
New +$11.4M
DMTK
124
DELISTED
DermTech, Inc. Common Stock
DMTK
$10.2M 0.05%
200,000
-661,090
-77% -$34.6M
QURE icon
125
uniQure
QURE
$3.22B
$10.1M 0.05%
300,000
– –
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Farallon Capital Management held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Farallon Capital Management's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Farallon Capital Management's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Farallon Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Farallon Capital Management's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Farallon Capital Management opened 120 new positions and closed 20 in Q1 2021.
  • Farallon Capital Management's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.